Slides on Medical Minute 1: Endogenous Incretins

Learn about endogenous incretins, their downstream effects, and role in type 2 diabetes.
Carol Hatch Wysham, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.12 MB
Released: August 9, 2021

Acknowledgements

Provided by Clinical Care Options

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Endocrine Society Logo
Supported by an educational grant from
Lilly

Related Content

Experts discuss practical use of CGM in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)

Martin J. Abrahamson, MD, FACP
Program Director
Leslie Eiland, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credit Released: May 27, 2022 Expired: May 26, 2023

Clinical Care Options (CCO) presents Dr. Jane Jeffrie Seley discussing the importance of patient education and training when managing T2D treatment in older patients

Jane Jeffrie Seley, DNP, MPH, MSN, GNP, BC-ADM, CDCES Released: May 4, 2022

Expert faculty insight on evidence for finerenone use in DKD, selecting patients for therapy, overcoming clinical inertia, from ProCE

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Pharmacists: 1.5 contact hours (0.15 CEUs) Released: April 29, 2022 Expired: April 28, 2023

Downloadable slides on CGM use in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)

Martin J. Abrahamson, MD, FACP
Program Director
Leslie Eiland, MD
Released: April 27, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings